v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (4,746) $ (5,432) $ (6,752)
Depreciation and amortization 1,031 937 652
Stock-based compensation expense 692 821 987
Loss on convertible notes, net (Note 10) (112) 0 0
Inventory LCNRV write-downs and losses on firm purchase commitments 0 107 920
Other non-cash activities 28 115 82
Changes in operating assets and liabilities:      
Accounts receivable, net (282) (59) (76)
Inventory 307 (1,604) (1,657)
Other assets (221) (146) (36)
Accounts payable and accrued liabilities (572) 105 623
Deferred revenue 1,619 149 61
Other liabilities 316 141 144
Net cash used in operating activities (1,716) (4,866) (5,052)
Cash flows from investing activities:      
Purchases of short-term investments (4,392) (2,410) 0
Maturities of short-term investments 3,553 925 0
Capital expenditures (1,141) (1,026) (1,369)
Net cash used in investing activities (1,980) (2,511) (1,369)
Cash flows from financing activities:      
Proceeds from issuance of capital stock including employee stock purchase plan 64 61 102
Proceeds from issuance of convertible notes 1,000 3,195 0
Proceeds from funding of 50% interest in Rivian and VW Group Technology, LLC 79 0 0
Purchase of capped call options 0 (108) 0
Other financing activities (7) (18) (3)
Net cash provided by financing activities 1,136 3,130 99
Effect of exchange rate changes on cash and cash equivalents (3) 5 (2)
Net change in cash (2,563) (4,242) (6,324)
Cash, cash equivalents, and restricted cash—Beginning of period   12,099 18,423
Cash, cash equivalents, and restricted cash—End of period     12,099
Supplemental disclosure of cash flow information:      
Cash paid for interest 279 169 88
Supplemental disclosure of non-cash investing and financing activities:      
Capital expenditures included in liabilities 423 374 364
Capital stock issued to settle bonuses 179 137 0
Conversion of convertible notes $ 1,133 $ 0 $ 0